IMPACT OF SWITCHING FROM DUAL TO TRIPLE THERAPY ON INFLAMMATION: A RANDOMIZED MULTICENTER OPEN LABEL CLINICAL TRIAL

• ACRONYM: InSTINCT
• FSG CODE: GESIDA 10918
• COORDINATOR: SANTIAGO MORENO/SERGIO SERRANO
• COORDINATOR’S HOSPITAL: HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL, MADRID
• APPROVAL DATE: 18-SEP.-2018
• PROTOCOL STATUS: ANALYZING DATA / PUBLISHED 
• CEIC-S APPROVAL: YES
• AEMYPS APPROVAL: YES
• ENROLED PATIENTS: 140
• TOTAL NUMBER OF PATIENTS TO INCLUDE: 242
• SCIENTIFIC OUTPUT: PUBLISHED